BridgeBio Pharma
BBIO
BBIO
247 hedge funds and large institutions have $6.76B invested in BridgeBio Pharma in 2023 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 89 increasing their positions, 77 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
247
Holders Change
+26
Holders Change %
+11.76%
% of All Funds
3.62%
Holding in Top 10
15
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+50%
% of All Funds
0.22%
New
53
Increased
89
Reduced
77
Closed
26
Calls
$110M
Puts
$90.1M
Net Calls
+$20.2M
Net Calls Change
-$12.9M
Top Buyers
| 1 |
1
Lord, Abbett & Co
Jersey City,
New Jersey
|
$125M |
| 2 |
2
Morgan Stanley
New York
|
$134M |
| 3 |
3
Goldman Sachs
New York
|
$132M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$517M |
| 5 |
5
BlackRock
New York
|
$410M |
